Clinical Trial

Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The research study is to learn how the ACLP can best support patients with stable HR+/HER2- MBC.
Trial Details
NCT Number NCT07179809
Lead Sponsor M.D. Anderson Cancer Center
Conditions Metastatic Breast Cancer
Enrollment 100 participants
Start Date 2026-12-28
Primary Completion 2027-10-01 (estimated)
Study Completion 2029-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-12